After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

The success of Dupixent has demonstrated the viability of biologics in COPD ... potentially reshaping treatment standards and reinforcing AstraZeneca’s leadership in respiratory and immunology ...

UK pharma major AstraZeneca’s Fasenra (benralizumab), with its highly anticipated Phase III data to be showcased at the 2025 ...

“Emphysema makes it hard to breathe air out of your lungs as it affects the tiny air sacs at the end of the airways where ...

Share on Pinterest PongMoji/Getty Images Spirometry is an important tool for diagnosing and determining treatment for chronic obstructive pulmonary disease (COPD). This breathing test can detect ...

The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to solidify AstraZeneca’s position in the market.

New Study Shows Promising Results for COPD Treatment Nov. 20, 2024 — A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave ...

Sharada Gudur, a Respiratory Medicine Consultant at Lancashire Teaching Hospitals and a respiratory champion for Lancashire and South Cumbria Integrated Care Board, recently joined representatives ...

Study identifies NMLR as a predictor of 5-year mortality in COPD patients, paving the way for personalised care and improved survival outcomes.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A mega campaign to test 1.5 lakh people for tuberculosis (TB) under ‘TB Mukt Indore’ is set to be launched on January 26, ...

How many cases of HMPV has India reported? The answer is: more than 15. Meanwhile, China said, “...the increase of reports ...